B

Bio-Rad Laboratories IncClass A
D

BIO

325.58
USD
1.78
(0.55%)
Market Closed
Volume
6,844
EPS
9
Div Yield
-
P/E
-7
Market Cap
9,074,128,832
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    ICUI
    -4.120
    (-2.40%)
    167.760 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    M
    MASI
    0.910
    (0.57%)
    161.070 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.37 USD
    More
News

Title: Bio/Rad Laboratories IncClass A

Sector: Healthcare
Industry: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.